How Have You Been Utilizing Idelalisb and Ibrutinib in CLL

How Have You Been Utilizing Idelalisb and Ibrutinib in CLL

User Photo
ASHReport

4 years
374 Views
Share Report
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
Dr. Joshua Brody, MD @joshuabrodyMD Director, Lymphoma Immunotherapy Program Icahn School of Medicine at Mount Sinai talks about Utilizing Idelalisb and Ibrutinib in CLL at ASH 2015
Up Next Autoplay